FrancophonIA/ELRC3.0 huggingface dataset:
English: When treating patients who have at least one risk factor for development of congestive heart failure (e.g. prior myocardial infarction or symptomatic coronary artery disease or the elderly), physicians should start with the lowest available dose and increase the dose gradually.
Estonian: Pioglitasoon võib põhjustada vedeliku retentsiooni, mis võib esile kutsuda või süvendada südamepuudulikkust.Vähemalt ühe kongestiivse südamepuudulikkuse (nt eelnev müokardi infarkt või sümptomaatiline koronaartõbi või eakad) riskifaktoriga patsientide ravimisel,peaksid arstid patsientidel ravi alustama väikseimast võimalikust annusest ning annust tuleks järk-järgult tõsta.
English: Accord Healthcare Limited Sage House,
Estonian: Accord Healthcare Limited.
English: Your doctor may increase the dose to a maximum of 45 mg once a day.
Estonian: Arst võib annust suurendada maksimaalselt 45 mg ööpäevas.
English: common (may affect up to 1 in 10 people) - headache - dizziness - joint pain - impotence - back pain - shortness of breath - small reduction in red blood cell count - flatulence uncommon (may affect up to 1 in 100 people) - sugar in urine, proteins in urine - increase in enzymes - spinning sensation (vertigo) - sweating - tiredness
Estonian: sage (võib esineda kuni 1 inimesel 10-st) - peavalu - pearinglus - liigesvalu - impotentsus - seljavalu - õhupuudus - punaliblede arvu vähene langus - kõhupuhitus - kõhupuhitus aeg-ajalt (võib esineda kuni 1inimesel 100-st) - suhkur uriinis, valgud uriinis - ensüümide tõus - peapööritus (vertiigo) - higistamine
English: Pioglitazone treatment may be initiated at 15 mg or 30 mg once daily.
Estonian: Pioglitasoon-ravi algannus on 15 mg või 30 mg üks kord ööpäevas.
English: If you forget to take Pioglitazone Accord
Estonian: Kui te unustate Pioglitazone Accord'i võtta
English: 6 In active comparator controlled trials mean weight increase with pioglitazone given as monotherapy was 2-3 kg over one year.
Estonian: 6Aktiivsetes võrdlevates kontrolluuringutes, kus pioglitasooni anti monoteraapiana, tõusis kehakaal keskmiselt 2-3 kg ühe aasta jooksul.
English: The Prescriber Guide highlights the following:
Estonian: Ravimi väljakirjutamise juhises peab olema esile tõstetud järgnev informatsioon:
English: Aluminium/aluminium blisters, packs of 14, 28, 30, 50, 56, 84, 90, 98, 112 and 196 tablets.
Estonian: Alumiinium/alumiiniumblister; 14, 28, 30, 50, 56, 84, 90, 98, 112 ja 196 tabletiga pakendid Kõik pakendi suurused ei pruugi olla müügil.
English: Package Leaflet: Information for the patient
Estonian: Pakendi infoleht: teavekasutajale
English: Broken bones have been reported commonly (may affect up to 1 in 10 people) in female patients taking Pioglitazone Accord and have also been reported in male patients (frequency cannot be estimated from the available data) taking Pioglitazone Accord.
Estonian: Pioglitazone Accord'i kasutanud naispatsientidel on sageli teatatud luumurdudest (võib esineda kuni 1inimesel 10-st), samuti on luumurdudest teatatud Pioglitazone Accord'i kasutanud meespatsientidel (sagedust ei saa hinnata olemasolevate andmete alusel).
English: 7 In clinical trials with pioglitazone the incidence of elevations of ALT greater than three times the upper limit of normal was equal to placebo but less than that seen in metformin or sulphonylurea comparator groups.
Estonian: 7Pioglitasooniga läbiviidud kliinilistes uuringutes esines ALAT aktiivsuse tõusu enam kui kolm korda üle normi ülemise piiri sama palju kui platseebo korral, kuid vähem kui metformiini või sulfonüüluurea kontrollgrupis.
English: Fractures were observed in 2.6% of women taking pioglitazone compared to 1.7% of women treated with a comparator.
Estonian: Luumurde esines 2,6% pioglitasooni saanud naistel, võrreldes 1,7%võrdlusravimit saanud naistega.
English: If you stop taking Pioglitazone Accord
Estonian: Kui te lõpetate Pioglitazone Accord'i võtmise
English: - a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea.
Estonian: - sulfonüüluurea, ainult neil täiskasvanud patsientidel, kellel ilmneb metformiini talumatus või kellele metformiin on vastunäidustatud ja kellel veresuhkru taseme kontroll on puudulik, vaatamata metformiini või sulfonüüluurea maksimaalselt talutavatele suukaudsetele annustele.
English: Therapy with pioglitazone should not be initiated in patients with increased baseline liver enzyme levels (ALT > 2.5 X upper limit of normal) or with any other evidence of liver disease.
Estonian: Pioglitasoonravi ei tohi alustada neil patsientidel, kellel maksaensüümi väärtused on tõusnud (ALT > 2,5 korda üle normi) või esineb mõni muu maksahaigusele viitav näitaja.
English: common common common common common blood creatine phosphokinase increased common increased lactic dehydrogenase uncommon alanine aminotransferase increased 7
Estonian: vere kreatiinfosfokinaasi tõus laktaatdehüdrogenaa si aktiivsuse tõus aeg-ajalt alaniinminotransferaasitõus7
English: • If you have a problem with your liver or heart.
Estonian: • kui teil esineb maksa- või südamehäireid.
English: It is not known whether pioglitazone is secreted in human milk.
Estonian: Ei ole teada, kas pioglitasoon eritubrinnapiima.
English: In most clinical trials, reduced total plasma triglycerides and free fatty acids, and increased HDLcholesterol levels were observed as compared to placebo, with small, but not clinically significant increases in LDL-cholesterol levels.
Estonian: Enamustes kliinilistes uuringutes vähenes plasma üldine triglütseriidide ja vabade rasvhapete tase ning tõusis HDL-kolesterooli tase, võrreldes platseeboga, ning LDL-kolesterooli taseme märkimisväärsed muutusedolid väikesed kuid kliiniliselt vähetähtsad.
English: Each tablet contains 111.70 mg of lactose monohydrate (see section 4.4).
Estonian: Iga tablett sisaldab 111,70 mg laktoosmonohüdraati (vt. lõik 4.4).
English: Reproductive system and breast disorders erectile dysfunction common
Estonian: Reproduktiivsesüst eemijarinnanäärme häired erektsioonihäired
English: The risk of fractures should be considered in the long term care of patients treated with pioglitazone (see section 4.8).
Estonian: Pioglitasooniga ravitavatel patsientidel tuleks pikaajalise ravi korral arvesse võtta murdude esinemise riski (vt lõik 4.8).
English: common (may affect up to 1 in 10 people) - respiratory infection - abnormal vision - weight gain - numbness uncommon (may affect up to 1 in 100 people) - inflammation of the sinuses (sinusitis) - difficulty sleeping (insomnia)
Estonian: sage (võib esinedakuni 1inimesel 10-st) - hingamisteede põletikud - nägemishäire - kehakaalu tõus - tuimus aeg-ajalt (võib esineda kuni 1inimesel 100-st) - põskkoopapõletik - unetus (insomnia)
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
Estonian: ESMASE MÜÜGILOA VÄLJASTAMISE/MÜÜGILOA UUENDAMISE KUUPÄEV Müügiloa esmase väljastamise kuupäev: 21 Märts 2012
English: What Pioglitazone Accord contains
Estonian: Mida Pioglitazone Accordsisaldab
English: Each tablet contains 37.24 mg of lactose monohydrate (see section 4.4).
Estonian: Iga tablett sisaldab 37,24 mg laktoosmonohüdraati (vt. lõik 4.4).
English: 4 A pooled analysis was conducted of adverse reactions of bone fractures from randomised, comparator controlled, double blind clinical trials in over 8100 patients in the pioglitazone-treated groups and 7400 in the comparator-treated groups of up to 3.5 years duration.
Estonian: 4Luumurdude kõrvaltoimete teadete põhjal viidi läbi ühisanalüüs randomiseeritud, võrdlusravimiga kontrollitud, topelt-pimedadkuni 3,5 aastat kestnud kliinilised uuringud, mis hõlmasid 8100 pioglitasooniga ravitud patsiendigrupi ja 7400 võrdlusravimiga ravitud patsiendigrupi.
English: The other side effects that have been experienced by some patients when Pioglitazone Accord is taken with other antidiabetic medicines:
Estonian: Muud kõrvaltoimed, mis on esinenudPioglitazone Accord'i koos mõne teise diabeediravimiga kasutanud patsientidel, hõlmavad järgmist:
English: 1 Postmarketing reports of hypersensitivity reactions in patients treated with pioglitazone have been reported.
Estonian: 1Pioglitasooniga ravitud patsientidel on turuletulekujärgselt teatatud ülitundlikkusreaktsioonidest.
English: Carmellose calcium Hydroxypropyl cellulose Lactose monohydrate Magnesium stearate
Estonian: HüdroksüpropüültselluloosLaktoosmonohüdraat Magneesiumsteraat
English: Pioglitazone Accord contains pioglitazone.
Estonian: Pioglitazone Accordsisaldab pioglitasooni.
English: PSURs
Estonian: PSURid
English: How to take Pioglitazone Accord
Estonian: Kuidas Pioglitazone Accord'i kasutada
English: Pioglitazone Accord 15 mg tablets Pioglitazone Accord 30 mg tablets Pioglitazone Accord 45 mg tablets
Estonian: RAVIMPREPARAADI NIMETUS Pioglitazone Accord 15 mg tabletid Pioglitazone Accord 30 mg tabletid Pioglitazone Accord 45 mg tabletid
English: • The other ingredients are lactose monohydrate, carmellose calcium, hydroxypropyl cellulose (E
Estonian: • Abiained on laktoosmonohüdraat, karmellooskaltsium, hüdroksüpropüültselluloos
English: Each tablet contains 74.46 mg of lactose monohydrate (see section 4.4).
Estonian: Iga tablett sisaldab 74,6 mg laktoosmonohüdraati (vt. lõik 4.4).
English: B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
Estonian: B. MÜÜGILOA HOIDJALE ESITATUD HANKE- JA KASUTUSTINGIMUSED VÕI PIIRANGUD
English: A higher rate of fractures was observed in women taking pioglitazone (2.6%) versus comparator (1.7%).
Estonian: Suurem murdude esinemissagedus oli pioglitasooni saanud naistel(2,6%), võrreldes võrdlusravimiga (1,7%).
English: No special requirements for disposal.
Estonian: Erinõuded hävitamisekspuuduvad.
English: Pioglitazone Accord helps control the level of sugar in your blood when you have type 2 diabetes by helping your body make better use of the insulin it produces.
Estonian: Pioglitazone Accordaitab reguleerida veresuhkru taset II tüüpi suhkurtõve puhul, aidates organismil paremini ära kasutada toodetavat insuliini.Teie arst kontrollib, kas ravim toimib 3 kuni 6 kuud pärast selle kasutama hakkamist.
English: Pioglitazone Accord 15 mg tablets: 3 years Pioglitazone Accord 30 mg/ 45 mg tablets: 4 years
Estonian: Pioglitazone Accord 30 mg/ 45 mg tabletid: 4 aastat.
English: Allergic reactions have been reported (frequency cannot be estimated from the available data) in patients taking Pioglitazone Accord.
Estonian: Pioglitazone Accord'i kasutavad patsiendid on teatanud allergilistest reaktsioonidest (sagedust ei saa hinnata olemasolevate andmete alusel).
English: Localised swelling (oedema) has also been experienced very commonly (may affect more than 1 in 10 people) in patients taking Pioglitazone Accord in combination with insulin.
Estonian: Pioglitazone Accord'i koos insuliiniga kasutanud patsientidel on väga sageli esinenud ka lokaliseeritud paistetust (turse)(võib esineda rohkem kui 1 inimesel 10-st).
English: 319 Pinner Road, North Harrow,
Estonian: Accord Healthcare Limited Sage House, 319 Pinner road, North Harrow, HA1 4HF, Middlesex, Ühendkuningriik
English: Blurred vision due to swelling (or fluid) at the back of the eye (frequency cannot be estimated from the available data) has also been reported in patients taking Pioglitazone Accord.
Estonian: Pioglitazone Accord'i kasutavad patsiendid on teatanud ka hägusast nägemisest paistetuse (või vedeliku) tõttu silma tagaosas (sagedust ei saa hinnata olemasolevate andmete alusel).
English: • Each Pioglitazone Accord 30 mg tablet contains 30 mg of pioglitazone (as hydrochloride).
Estonian: • Iga Pioglitazone Accord 30 mg tablett sisaldab 30 mg pioglitasooni (vesinikkloriidina).
English: The MAH shall provide an educational pack targeting all physicians who are expected to prescribe/use Pioglitazone.
Estonian: Müügiloa hoidja tagab kõikide raviarstide, kes võivad välja kirjutada või raviks kasutada Pioglitasooni, varustamise vajaliku teabematerjaliga.
English: EU/1/11/722/001-010 (14/28/30/50/56/84/90/98/112/196 tablets in alu/alu blister) EU/1/11/722/011-020 (14/28/30/50/56/84/90/98/112/196 tablets in alu/alu blister) EU/1/11/722/021-030 (14/28/30/50/56/84/90/98/112/196 tablets in alu/alu blister)
Estonian: EU/1/11/722/011-020 (14/28/30/50/56/84/90/98/112/196 tabletti alu/alu blistrid) EU/1/11/722/021-030 (14/28/30/50/56/84/90/98/112/196 tabletti alu/alu blistrid)
English: NAME OF THE MARKETING AUTHORISATION HOLDER Accord (Logo)
Estonian: MÜÜGILOA HOIDJA NIMI
English: • Pioglitazone Accord 45 mg tablets are white to off white, flat, round uncoated tablets with beveled edges debossed with ‘PIO' on one side and ‘45' on the other side.
Estonian: • Pioglitazone Accord 45 mg tabletid tabletid on valged või määrdunudvalged, lamedad, ümmargused kaldservadega ja katmata, mille ühele küljele on sisse pressitud märgistus „PIO” ning teisele küljele „45”.
English: A cardiovascular outcome study of pioglitazone has been performed in patients under 75 years with type 2 diabetes mellitus and pre-existing major macrovascular disease.
Estonian: II tüüpi diabeediga ja eelneva makrovaskulaarse haigusega alla 75 aastaste patsientide seas viidi läbi kardiovaskulaarne kaugtulemusi hindav pioglitasooni uuring.
English: • Each Pioglitazone Accord 45 mg tablet contains 45 mg of pioglitazone (as hydrochloride).
Estonian: • Pioglitazone Accord 45 mg tablett sisaldab 45 mg pioglitasooni (vesinikkloriidina).
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING
Estonian: VÄLISPAKENDIL ESITATAVAD ANDMED
English: Post marketing cases of peripheral oedema and cardiac failure have also been reported in patients with concomitant use of pioglitazone and nonsteroidal anti-inflammatory drugs, including selective COX-2 inhibitors.
Estonian: Kuna insuliin ja pioglitasoon on seotud vedeliku retentsiooniga, siis nende üheaegne manustamine võib suurendada tursete tekkeohtu.Pioglitasooni ja mittesteroidseid põletikuvastaseid ravimeid, sealhulgas selektiivseid COX-2 inhibiitoreid samaaegselt kasutanud patsientidel teavitati turuletuleku järgselt ka perifeersete tursete ja südamepuudulikkuse juhtudest.
English: The European Medicines Agency has waived the obligation to submit the results of studies with Pioglitazone in all subsets of the paediatric population in Type 2 Diabetes Mellitus.
Estonian: Euroopa Ravimiamet eikohustaesitama Pioglitazone ega läbi viiduduuringute tulemusi laste kõikidealarühmade kohta II tüüpi diabeedinäidustuse korral(teave lastel kasutamise kohta:vt lõik 4.2).
English: Metabolism and nutrition disorders hypo-glycaemia uncommon very common common appetite increased uncommon
Estonian: Ainevahetus- ja toitumishäired hüpoglükeemia aeg-ajalt väga sage
English: • Pioglitazone Accord 15 mg tablets are white to off white, round, biconvex, uncoated tablets debossed with ‘P' on one side and ‘15' on other side.
Estonian: • Pioglitazone Accord 15 mg tabletid on valged või määrdunudvalged, ümmargused, kaksikkumerad ja katmata, milleühel küljel on sissepressitud märgistus„P” ning teisel küljel „15”.
English: Do not take Pioglitazone Accord: • if you are allergic to pioglitazone or any of the other ingredients of this medicine (listed in Section
Estonian: • kui te olete pioglitasoonivõi selle ravimimis taheskoostisosade (loetletud lõigus 6)
English: • Pioglitazone Accord 30 mg tablets are white to off white, flat, round uncoated tablets with beveled edges debossed with ‘PIO' on one side and ‘30' on the other side.
Estonian: • Pioglitazone Accord 30 mg tabletid on valged või määrdunudvalged, lamedad, ümmargused kaldservadega ja katmata, mille ühele küljele on sisse pressitud märgistus „PIO” ning teisele küljele „30”.
English: Combination with with sulpho with with insulin therapy metformin nylurea metformin and sulphonylurea
Estonian: Pioglitasooni kõrvaltoimete esinemissagedus ravirežiimi järgi Monoravi kombineeritud koos metformiiniga koos sulfonüüluureaga koos metformiin i ja sulfonüüluureaga koos insuliiniga
English: Oedema5
Estonian: Luumurd4
English: • Each Pioglitazone Accord 15 mg tablet contains 15 mg of pioglitazone (as hydrochloride).
Estonian: • Iga Pioglitazone Accord 15 mg tablett sisaldab 15 mg pioglitasooni (vesinikkloriidina).
English: If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Estonian: Kui teil onlisaküsimusi selleravimikasutamise kohta, pidage nõu oma arsti või apteekriga.
English: The other side effects that have been experienced by some patients taking Pioglitazone Accord are:
Estonian: Mõnedel Pioglitazone Accord'i kasutanudpatsientidel on esinenud alljärgnevaid kõrvaltoimeid:
English: Each tablet contains 45 mg of pioglitazone (as hydrochloride).
Estonian: Iga tablett sisaldab 45 mg pioglitasooni (vesinikkloriidina)
English: Pioglitazone Accord 45 mg tablets Pioglitazone
Estonian: Pioglitazone Accord 45 mg tabletid Pioglitasoon
English: common common uncommon macular oedema not known not known not known not known not known
Estonian: Makulaarne ödeem teadmata teadmata teadmata teadmata teadmata Kõrva ja labü-rindi kahjustused vertiigo aeg-ajalt
English: There may be an increased possibility of becoming pregnant because you may ovulate again when you take Pioglitazone Accord.
Estonian: Kui te võtatePioglitazone Accord'i, võib teil esineda ovulatsioon, mis suurendab rasestumise võimalust.
English: Pioglitazone Accord 15 mg tablets
Estonian: Pioglitazone Accord 15 mg tabletid
English: Pioglitazone Accord 45 mg tablets
Estonian: Pioglitazone Accord 45 mg tabletid
English: Hepatic impairment
Estonian: Healoomulised,
English: Each tablet contains 30 mg of pioglitazone (as hydrochloride).
Estonian: Iga tablett sisaldab 30 mg pioglitasooni (vesinikkloriidina)
English: Pioglitazone Accord 30 mg tablets
Estonian: Pioglitazone Accord 30 mg tabletid
English: Pioglitazone Accord 30 mg tablets Pioglitazone
Estonian: Pioglitazone Accord 30 mg tabletid Pioglitasoon
English: The tablets are white to off white, flat, round uncoated tablets with beveled edges debossed with ‘PIO' on one side and ‘45' on the other side.
Estonian: Tabletid on valged või määrdunudvalged, lamedad, ümmargused kaldservadega ja katmata, mille ühele küljele on sisse pressitud märgistus „PIO” ning teisele küljele „45”.
English: Each tablet contains 15 mg of pioglitazone (as hydrochloride).
Estonian: Iga tablett sisaldab 15 mg pioglitasooni (vesinikkloriidina)
English: Since there is a potential for an increase in doserelated adverse events, a decrease in the dose of pioglitazone may be needed when gemfibrozil is concomitantly administered.
Estonian: Kuna esineb potentsiaalne tõus annusega seotud kõrvaltoimetes, võib gemfibrosiili samaaegsel manustamisel osutuda vajalikuks pioglitasooni annuse vähendamine.Veresuhkru tasemeid tuleks täpselt jälgida (vt lõik 4.4).
English: Bladder cancer has been experienced uncommonly (may affect up to 1 in 100 people) in patients taking Pioglitazone Accord.
Estonian: Ravimit kasutanud patsientidel on aeg-ajalt (võib esineda kuni 1inimesel 100-st) esinenud põievähki.
English: Your doctor will ask you to have blood tests periodically during treatment with Pioglitazone Accord.
Estonian: Võttes Pioglitazone Accord'i tablette, palub teie arst teil regulaarsete intervallide tagant anda vereanalüüsi.
English: EU/1/11/722/001 14 tablets EU/1/11/722/002 28 tablets EU/1/11/722/003 30 tablets EU/1/11/722/004 50 tablets EU/1/11/722/005 56 tablets EU/1/11/722/006 84 tablets EU/1/11/722/007 90 tablets EU/1/11/722/008 98 tablets EU/1/11/722/009 112 tablets EU/1/11/722/010 196 tablets
Estonian: EU/1/11/722/001 14 tabletti EU/1/11/722/002 28 tabletti EU/1/11/722/003 30 tabletti EU/1/11/722/004 50 tabletti EU/1/11/722/005 56 tabletti EU/1/11/722/006 84 tabletti EU/1/11/722/007 90 tabletti EU/1/11/722/008 98 tabletti EU/1/11/722/009 112 tabletti EU/1/11/722/010 196 tabletti
English: The tablets are white to off white, flat, round uncoated tablets with beveled edges debossed with ‘PIO' on one side and ‘30' on the other side.
Estonian: Tabletid on valged või määrdunudvalged, lamedad, ümmargused kaldservadega ja katmata, mille ühele küljele on sisse pressitud märgistus „PIO” ning teisele küljele „30”.
English: EU/1/11/722/021 14 tablets EU/1/11/722/022 28 tablets EU/1/11/722/023 30 tablets EU/1/11/722/024 50 tablets EU/1/11/722/025 56 tablets EU/1/11/722/026 84 tablets EU/1/11/722/027 90 tablets EU/1/11/722/028 98 tablets EU/1/11/722/029 112 tablets EU/1/11/722/030 196 tablets
Estonian: EU/1/11/722/021 14 tabletti EU/1/11/722/022 28 tabletti EU/1/11/722/023 30 tabletti EU/1/11/722/024 50 tabletti EU/1/11/722/025 56 tabletti EU/1/11/722/026 84 tabletti EU/1/11/722/027 90 tabletti EU/1/11/722/028 98 tabletti EU/1/11/722/029 112 tabletti EU/1/11/722/030 196 tabletti
English: EU/1/11/722/011 14 tablets EU/1/11/722/012 28 tablets EU/1/11/722/013 30 tablets EU/1/11/722/014 50 tablets EU/1/11/722/015 56 tablets EU/1/11/722/016 84 tablets EU/1/11/722/017 90 tablets EU/1/11/722/018 98 tablets EU/1/11/722/019 112 tablets EU/1/11/722/020 196 tablets
Estonian: EU/1/11/722/011 14 tabletti EU/1/11/722/012 28 tabletti EU/1/11/722/013 30 tabletti EU/1/11/722/014 50 tabletti EU/1/11/722/015 56 tabletti EU/1/11/722/016 84 tabletti EU/1/11/722/017 90 tabletti EU/1/11/722/018 98 tabletti EU/1/11/722/019 112 tabletti EU/1/11/722/020 196 tabletti
English: as monotherapy - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is in appropriate because of contraindications or intolerance as dual oral therapy in combination with - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin
Estonian: Kahekordse suukaudseravina kombinatsioonis - metformiin, täiskasvanud patsientidel (eriti ülekaalulistel), kellel veresuhkru taseme kontroll on puudulik, vaatamata metformiini või sulfonüüluurea maksimaalselt talutavatele suukaudsetele annustele.
English: The tablets are white to off white, round, biconvex, uncoated tablets debossed with ‘P' on one side and ‘15' on other side.
Estonian: Tabletid on valged või määrdunudvalged, ümmargused kaksikkumerad ja katmata, mille ühele küljele on sisse pressitud märgistus „P” ning teisele küljele „15”.
English: Pioglitazone Accord 15 mg tablets Pioglitazone
Estonian: Pioglitazone Accord 15 mg tabletid Pioglitasoon
English: Heart failure has been experienced commonly (may affect up to 1 in 10 people) in patients taking Pioglitazone Accord in combination with insulin.
Estonian: Sageli on Pioglitazone Accord'iga samal ajal insuliini kasutanud patsientidel esinenud südamepuudulikkust (võib esineda kuni1inimesel 100-st).
English: Pioglitazone Accord 15 mg tablets Each tablet contains 15 mg of pioglitazone (as hydrochloride).
Estonian: KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS Pioglitazone Accord 15 mg tabletid Iga tablett sisaldab 15 mg pioglitasooni vesinikkloriidina.
English: Other medicines and Pioglitazone Accord
Estonian: Muudravimid jaPioglitazone Accord
English: Posology
Estonian: Infolehesisukord
English: Adverse reaction Frequency of adverse reactions of pioglitazone by treatment regimen
Estonian: Üldised häired ja manustamis-koha reaktsioonid Tursed5
English: Patients should be observed for signs and symptoms of heart failure, weight gain and oedema when pioglitazone is used in combination with insulin.
Estonian: Pioglitasooni kasutamisel koos insuliiniga või kui pioglitasooni kasutati südamepuudulikkuse anamneesiga patsientidel, on turustamisejärgselt teatatud südamepuudulikkuse juhtudest; südamepuudulikkuse, kaalutõusu ja tursete sümptomitega patsiente tuleb jälgida, kui pioglitasooni kasutatakse kombinatsioonis insuliiniga.
English: The pioglitazone dose may need to be increased when rifampicin is concomitantly administered.
Estonian: Rifampitsiini samaaegsel manustamisel võib osutuda vajalikuks pioglitasooni annuse suurendamine.
English: Bladder cancer
Estonian: Karmellooskaltsium
English: INFORMATION IN BRAILLE
Estonian: TEAVEBRAILLE' KIRJAS (PUNKTKIRJAS)
English: You may need to read it again.
Estonian: Teil võib olla vaja seda uuesti lugeda.
English: > 24 hours
Estonian: > 24 tundi
English: This is usually reversible and appears to be dose-dependent.
Estonian: See on tavaliselt taastuv ja näib sõltuvat doosist.